Aug 12, 2026 09:03AM
Aug 12, 2026 09:00AM
Aug 7, 2026 09:25AM
Aug 7, 2026 09:25AM
Jun 24, 2026 09:00AM
Jun 24, 2026 09:00AM
May 13, 2026 09:00AM Femasys receives CE mark approval for FemHSG fertility catheter in Europe
May 13, 2026 09:00AM
May 8, 2026 04:05PM
May 5, 2026 09:00AM
Apr 22, 2026 09:00AM
Apr 16, 2026 09:04AM
Apr 16, 2026 09:00AM
Apr 16, 2026 09:00AM Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
Apr 1, 2026 09:00AM
Apr 1, 2026 09:00AM
Mar 31, 2026 04:05PM
Mar 18, 2026 09:00AM
Mar 18, 2026 09:00AM
Mar 10, 2026 09:00AM
Mar 10, 2026 09:00AM Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
Mar 3, 2026 08:54AM
Feb 27, 2026 05:26PM
Feb 26, 2026 09:00AM
Feb 23, 2026 09:02AM
Feb 23, 2026 09:00AM
Feb 3, 2026 09:16AM
Feb 3, 2026 09:15AM Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
Jan 14, 2026 09:02AM
Jan 14, 2026 09:00AM
Jan 13, 2026 09:07AM
Jan 13, 2026 09:00AM
Dec 18, 2025 09:15AM
Dec 18, 2025 09:15AM
Nov 25, 2025 09:15AM PharmaCyte Biotech sells Femasys stake, boosts cash to $20 million
Nov 25, 2025 09:15AM
Nov 14, 2025 04:01PM
Nov 10, 2025 09:00AM
Nov 3, 2025 08:30AM
Nov 3, 2025 08:30AM
Oct 22, 2025 09:00AM
Oct 22, 2025 09:00AM Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
Oct 16, 2025 09:00AM
Oct 16, 2025 09:00AM
Sep 25, 2025 09:00AM
Sep 22, 2025 09:01AM
Sep 22, 2025 09:00AM
Sep 11, 2025 09:00AM
Sep 8, 2025 09:00AM Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
Sep 2, 2025 09:01AM

328,337 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All